Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury

Stroke

Volumn 36, Issue 6, 2005, Pages 1241-1246

  Reddrop, Courtney ^a   Moldrich, Randal X ^b   Beart, Philip M ^b,c   Farso, Mark ^c   Liberatore, Gabriel T ^c   Howells, David W ^c   Petersen, Karl Uwe ^d   Schleuning, Wolf Dieter ^e   Medcalf, Robert L ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d PAION Deutschland GmbH   (Germany)

^e NOXXON PHARMA AG   (Germany)

Author keywords

Excitotoxicity; Tissue plasminogen activator

Indexed keywords

CALCIUM; DESMOTEPLASE; N METHYL DEXTRO ASPARTIC ACID; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN INJURY; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; EXCITOTOXICITY; MOUSE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CALCIUM; CELL DEATH; FIBRINOLYTIC AGENTS; IMMUNOHISTOCHEMISTRY; INFUSIONS, INTRAVENOUS; ISCHEMIA; MICE; MICE, INBRED C57BL; N-METHYLASPARTATE; NEURONS; PLASMINOGEN ACTIVATORS; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 20444372592     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000166050.84056.48     Document Type: Article

References (27)

1. Levin EG, del Zoppo GJ. Localization of tissue plasminogen activator in the endothelium of a limited number of vessels. Am J Pathol. 1994;144: 855-861.
2. Seeds NW, Williams BL, Bickford PC. Tissue plasminogen activator induction in Purkinje neurons after cerebellar motor learning. Science. 1995;270:1992-1994.
3. Tsirka S, Rogove AD, Strickland S. Neuronal cell death and tPA. Nature. 1996;384:123-124.
4. Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, MacKenzie ET, Vivien D, Buisson A. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med. 2001; 7:59-64.
5. Wang X, Asahi M, Lo EH. Tissue-type plasminogen activator amplifies hemoglobin-induced neurotoxicity in rat neuronal cultures. Neurosci Lett. 1999;274:79-82.
6. Nagai N, Yamamoto S, Tsuboi T, Ihara H, Urano T, Takada Y, Terakawa S, Takada A. Tissue-type plasminogen activator is involved in the process of neuronal death by oxygen-glucose deprivation in culture. J Cereb Blood Flow Metab. 2001;21:631-634.
7. Kim Y-H, Park J-H, Hong SH, Koh JY. Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator. Science. 1999;284: 647-650.
8. Wang YF, Tsirka SE, Strickland S, Stieg PE, Soriano SG, Lipton SA. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med. 1998; 4:228-231.
9. Nagai N, Mol MD, Lijnen HR, Carmeliet P, Collen D. Role of plasminogen system components in focal cerebral ischaemic infarction: a gene targeting and gene transfer study in mice. Circulation. 1999;99: 2440-2444.
10. Kilic E, Hermann DM, Hossmann KA. Recombinant tissue plasminogen activator reduces infarct size after reversible thread occlusion of middle cerebral artery in mice. Neuroreport. 1999;10:107-111.
11. Tabrizi P, Wang L, Seeds N, McComb JG, Yamada S, Griffin JH, Carmeliet P, Weiss MH, Zlokovic BV. Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background. Arterioscler Thromb Vasc Biol. 1999;19:2801-2806.
12. Klein GM, Li H, Sun P, Buchan AM. Tissue plasminogen activator does not increase neuronal damage in rat models of global and focal ischemia. Neurology. 1999;52:1381-1384.
13. Meng W, Wang X, Asahi M, Kano T, Asahi K, Ackerman RH, Lo EH. Effects of tissue type plasminogen activator in embolic versus mechanical models of focal cerebral ischaemia in rats. J Cereb Blood Flow Metab. 1999;19:1316-1321.
14. Larrue V, von Kummer R, del Zoppo G, Bluhmki E. Hemorrhagic transformation in acute ischemic stroke: potential contributing factors in the European Cooperative Acute Stroke Study. Stroke. 1997;28:957-960.
15. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
16. Krätzschmar J, Haendler B, Langer G, Boidol W, Bringmann P, Alagon A, Donner P, Schleuning WD. The plasminogen activator family from the salivary gland of the vampire bat Desmodus rotundus: cloning and expression. Gene. 1991;105:229-237.
17. Liberatore GT, Samson A, Bladin C, Schleuning WD, Medcalf RL. Vampire bat salivary plasminogen activator (desmoteplase) - a unique fibrinolytic enzyme that does not promote neurodegeneration. Stroke. 2003;34:537-543.
18. Callaway JK, Knight MJ, Watkins DJ, Beart PM, Jarrott B, Delaney PM. A novel, rapid, computerized method for quantitation of neuronal damage in a rat model of stroke. J Neurosci Methods. 2000;102:53-60.
19. 2/3-mediated cAMP potentiation is calcium sensitive: studies in murine neuronal and astrocyte cultures. Neuropharmacology. 2002;43: 189-203.
20. Liu D, Cheng T, Guo H, Fernandez JA, Griffin JH, Song X, Zlokovic BV. Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C. Nat Med 2004;10:1379-1383.
21. Matys T, Strickland S. Tissue plasminogen activator and NMDA receptor cleavage. Nat Med. 2003;4:371-372.
22. Wang X, Lee SR, Arai K, Lee SR, Tsuji K, Rebeck GW, Lo EH. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat Med. 2003;9:1313-1317.
23. Yepes M, Sandkvist M, Moore EG, Bugge TH, Strickland DK, Lawrence DA. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Invest. 2003;112:1533-1540.
24. Bacskai BJ, Xia MQ, Strickland DK, Rebeck GW, Hyman BT. The endocytic receptor protein LRP also mediates neuronal calcium signaling via N-methyl-D-aspartate receptors. Proc Natl Acad Sci U S A. 2000;97: 11551-11556.
25. Okada Y, Copeland BR, Fitridge R, Koziol JA, del Zoppo GJ. Fibrin contributes to microvascular obstructions and parenchymal changes during early focal cerebral ischemia and reperfusion. Stroke. 1994;25: 1847-1854.
26. Toschi L, Bringmann P, Petri T, Donner P, Schleuning WD. Fibrin selectivity of the isolated protease domains of tissue-type and vampire bat salivary gland plasminogen activators. Eur J Biochem. 1998;252: 108-112.
27. Renatus M, Stubbs MT, Huber R, Bringmann P, Donner P, Schleuning WD, Bode W. Catalytic domain structure of vampire bat plasminogen activator: a molecular paradigm for proteolysis without activation cleavage. Biochemistry. 1997;36:13483-13493.